Sold as Gamophen, Phisohex, Soy-Dome, Hexa-Germ, Germa-Medica and 11 more. Every FDA application for this active ingredient.
As of Nov 13, 2026, FDA lists 17 applications for Hexachlorophene (sold as Gamophen, Phisohex, Soy-Dome and others), first approved Apr 19, 1949, with 0 new uses approved and 0 published complete response letters.
| Apr 19, 1949 | PhisohexNDA 6882 | Sanofi Aventis US | 11 | Discontinued |
| Sep 18, 1974 | Hexa-GermNDA 17411 · New dosage form | Huntington Labs | 0 | Discontinued |
| Mar 10, 1976 | DialNDA 17421 · New formulation or manufacturer | Dial | 0 | Discontinued |
| Jul 8, 1976 | E-Z ScrubNDA 17452 · New dosage form | Becton Dickinson | 3 | Discontinued |
| Feb 22, 1977 | Scrubteam Surgical SpongebrushNDA 17413 · New formulation or manufacturer | 3m | 1 | Discontinued |
| Aug 1, 1977 | Phiso-ScrubNDA 17446 · New formulation or manufacturer | Sanofi Aventis US | 1 | Discontinued |
| Feb 3, 1978 | Germa-Medica, Germa-Medica "Mg"NDA 17412 · New formulation or manufacturer | Huntington Labs | 3 | Discontinued |
| Oct 12, 1978 | Pre-Op, Pre-Op IiNDA 17433 · New formulation or manufacturer | Davis And Geck | 15 | Marketed |
| — | GamophenNDA 6270 | Arbrook | 2 | Discontinued |
| — | PhisohexNDA 8402 | Sanofi Aventis US | 0 | Discontinued |
| — | Soy-DomeNDA 17405 | Bayer Pharms | 0 | Discontinued |
| — | SeptisolNDA 17423 | Vestal Labs | 0 | Discontinued |
| — | SeptisolNDA 17424 | Vestal Labs | 0 | Discontinued |
| — | Septi-SoftNDA 17460 | Calgon | 0 | Discontinued |
| — | HexascrubNDA 18363 | Prof Dspls | 0 | Discontinued |
| — | TurgexNDA 18375 | Xttrium | 0 | Discontinued |
| — | TurgexNDA 19055 | Xttrium | 0 | Discontinued |
Applications, approvals and products come from FDA's Drugs@FDA data files, refreshed weekly, grouped by active ingredient as FDA spells it. Complete response letters are FDA's published letters. Medicare spending is CMS's Part D and Part B dashboard, matched to this ingredient by generic name; shortages are FDA's shortage list, matched by application number; clinical trials are ClinicalTrials.gov studies naming the ingredient as an intervention, refreshed daily; safety programs are FDA's REMS list, matched by application number or, for shared programs, by ingredient. Drugs@FDA